1. A viscous aqueous solution for injection with a half-life in human connective tissue more than 1 week for use in treating diseases of the veins, characterized venami.2 enhanced. A solution according to claim 1, comprising one or more of the following compounds:. Polylactic acid, alginate and hyaluronic kislotu.3. A solution of n. 2, comprising from 0.1% to 3% hyaluronic acid cross-linked is preferably 1,4-butanediol diglycidyl ether (BDDE) .4. A solution of n. 2, wherein the concentration of hyaluronic acid is from 0.25% to 2%, preferably from 0.5 to 1 .5%. A solution according to claim. 2-4, wherein the molecular weight of hyaluronic acid is from 1 million to 8 millionov Da.6. A solution according to claim. 1-4, further comprising a local anestetik.7. A solution of n. 6, wherein the local anesthetic from the group consisting skandikain, mepivacaine, cocaine, procaine, benzocaine (ethoform), lidocaine, mepivacaine, bupivacaine, ropivacaine, etidocaine, prilocaine and tetrakain.8. A solution according to claim. 1-4, wherein the venous disease is selected from the group consisting of aneurysm, varicose veins, venous insufficiency, varicose veins and ektazii.9. System catheter comprising a cannula to a vascular puncture site with double or triple rezom tip, comprising, (i) an outer cannula (non-cutting member), tube-like structure, characterized by a certain flexibility, in which (a) zone narrows to facilitate administration, (b) edge, possibly rounded to provide an atraumatic advancement, (c) may contain a connector with a connector type Luer-lock, (ii) a flexible and bendable hollow needle, (a) which may contain a transparent pavilion, and wherein (b) needle diameter smaller than the outer portion , with ( iii) a needle and an outer cannula connected to a temporary connector for about1. Вязкий водный раствор для инъекций с периодом полужизни в соединительной ткани человека более 1 недели для применения в лечении заболеваний вен, характеризующихся расширенными вена
